日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Nanobody-Based Lateral Flow Assay for Point-of-Care Diagnostics

一种基于纳米抗体的侧向流动检测方法用于即时诊断

Bates, Timothy A; Gurmessa, Sintayehu K; Reyes-Weinstein, Jules B; Barklis, Eric; Tafesse, Fikadu G

Mapping SARS-CoV-2 Nucleocapsid Function with Nanobodies

利用纳米抗体绘制SARS-CoV-2核衣壳功能图谱

Reyes-Weinstein, Jules B; Bates, Timothy A; Anastas, Aidan; Alfahdli, Ayna; Trank-Green, Mila; McBride, Savannah K; Garcia, Michelle; Parson, Matthew A H; Jenkins, Meredith L; Burke, John E; Barklis, Eric; Tafesse, Fikadu G

Immune imprinting and vaccination interval underly XBB.1.5 monovalent vaccine immunogenicity

免疫印迹和疫苗接种间隔是XBB.1.5单价疫苗免疫原性的基础

Wrynla, Xammy H; Bates, Timothy A; Trank-Greene, Mila; Wahedi, Mastura; Hinchliff, Audrey; Curlin, Marcel E; Tafesse, Fikadu G

Immune imprinting and vaccine interval determine antibody responses to monovalent XBB.1.5 COVID-19 vaccination.

免疫印迹和疫苗间隔决定了对单价 XBB.1.5 COVID-19 疫苗的抗体反应

Wrynla Xammy Huu, Bates Timothy A, Trank-Greene Mila, Wahedi Mastura, Hinchliff Audrey, Curlin Marcel E, Tafesse Fikadu G

Evaluating Humoral Immunity Elicited by XBB.1.5 Monovalent COVID-19 Vaccine

评估XBB.1.5单价新冠疫苗诱导的体液免疫

Nguyenla, Xammy Huu; Bates, Timothy A; Trank-Greene, Mila; Wahedi, Mastura; Tafesse, Fikadu G; Curlin, Marcel E

A nanobody interaction with SARS-COV-2 Spike allows the versatile targeting of lentivirus vectors.

纳米抗体与 SARS-COV-2 刺突蛋白的相互作用使得慢病毒载体能够进行多样化的靶向治疗

Alfadhli Ayna, Bates Timothy A, Barklis Robin Lid, Romanaggi CeAnn, Tafesse Fikadu G, Barklis Eric

Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection

SARS-CoV-2突破性感染后的抗体反应和变异株交叉中和作用

Bates, Timothy A; McBride, Savannah K; Winders, Bradie; Schoen, Devin; Trautmann, Lydie; Curlin, Marcel E; Tafesse, Fikadu G

A Single Dose of ChAdOx1 nCoV-19 Vaccine Elicits High Antibody Responses in Individuals with Prior SARS-CoV-2 Infection Comparable to That of Two-Dose-Vaccinated, SARS-CoV-2-Infection-Naïve Individuals: A Longitudinal Study in Ethiopian Health Workers

单剂 ChAdOx1 nCoV-19 疫苗在既往感染过 SARS-CoV-2 的个体中诱导产生的抗体反应与接种两剂疫苗的未感染过 SARS-CoV-2 的个体相当:一项针对埃塞俄比亚卫生工作者的纵向研究

Gelanew, Tesfaye; Mulu, Andargachew; Abebe, Markos; Bates, Timothy A; Wassie, Liya; Teferi, Mekonnen; Fentahun, Dessalegn; Alemu, Aynalem; Tamiru, Frehiwot; Assefa, Gebeyehu; Bayih, Abebe Genetu; Tafesse, Fikadu G; Mihret, Adane; Abdissa, Alemseged

High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers

埃塞俄比亚医护人员中抗SARS-CoV-2抗体血清阳性率较高

Gelanew, Tesfaye; Seyoum, Berhanu; Mulu, Andargachew; Mihret, Adane; Abebe, Markos; Wassie, Liya; Gelaw, Baye; Sorsa, Abebe; Merid, Yared; Muchie, Yilkal; Teklemariam, Zelalem; Tesfaye, Bezalem; Osman, Mahlet; Jebessa, Gutema; Atinafu, Abay; Hailu, Tsegaye; Habte, Antenehe; Kenea, Dagaga; Gadisa, Anteneh; Admasu, Desalegn; Tesfaye, Emnet; Bates, Timothy A; Bulcha, Jote Tafese; Tschopp, Rea; Tsehay, Dareskedar; Mullholand, Kim; Howe, Rawleigh; Genetu, Abebe; Tafesse, Fikadu G; Abdissa, Alemseged

A single dose ChAdOx1 nCoV-19 vaccine elicits high antibody responses in individuals with prior SARS-CoV-2 infection comparable to that of double dose vaccinated SARS-CoV-2 infection naïve individuals

单剂 ChAdOx1 nCoV-19 疫苗可在既往感染过 SARS-CoV-2 的个体中诱导产生与接种两剂疫苗的未感染过 SARS-CoV-2 的个体相当的高抗体反应。

Gelanew, Tesfaye; Mulu, Andargachew; Abebe, Markos; Bates, Timothy A; Wassie, Liya; Tefer, Mekonnen; Fentahun, Desalegn; Alemu, Aynalem; Tamiru, Frehiwot; Assefa, Gebeyehu; Bayih, Abebe Genetu; Taffesse, Fikadu G; Mihret, Adane; Abdissa, Alemseged